Clinica Baviera (CBAV) - Net Assets

Latest as of September 2025: €97.36 Million EUR ≈ $113.83 Million USD

Based on the latest financial reports, Clinica Baviera (CBAV) has net assets worth €97.36 Million EUR (≈ $113.83 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€228.01 Million ≈ $266.57 Million USD) and total liabilities (€130.65 Million ≈ $152.74 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Clinica Baviera (CBAV) liquid assets ratio to evaluate the company's liquid asset resilience ratio.

Key Net Assets Metrics

Metric	Value
Current Net Assets	€97.36 Million
% of Total Assets	42.7%
Annual Growth Rate	10.67%
5-Year Change	119.04%
10-Year Change	361.52%
Growth Volatility	17.57

Clinica Baviera - Net Assets Trend (2005–2024)

This chart illustrates how Clinica Baviera's net assets have evolved over time, based on quarterly financial data. Also explore Clinica Baviera asset portfolio for the complete picture of this company's asset base.

Annual Net Assets for Clinica Baviera (2005–2024)

The table below shows the annual net assets of Clinica Baviera from 2005 to 2024. For live valuation and market cap data, see CBAV company net worth.

Year	Net Assets	Change
2024-12-31	€98.36 Million ≈ $114.99 Million	+6.59%
2023-12-31	€92.28 Million ≈ $107.88 Million	+34.97%
2022-12-31	€68.37 Million ≈ $79.93 Million	+23.42%
2021-12-31	€55.39 Million ≈ $64.76 Million	+23.36%
2020-12-31	€44.90 Million ≈ $52.50 Million	+45.77%
2019-12-31	€30.80 Million ≈ $36.01 Million	+7.09%
2018-12-31	€28.76 Million ≈ $33.63 Million	+15.62%
2017-12-31	€24.88 Million ≈ $29.09 Million	+33.94%
2016-12-31	€18.57 Million ≈ $21.72 Million	-12.84%
2015-12-31	€21.31 Million ≈ $24.92 Million	+5.49%
2014-12-31	€20.20 Million ≈ $23.62 Million	-20.29%
2013-12-31	€25.35 Million ≈ $29.63 Million	+21.52%
2012-12-31	€20.86 Million ≈ $24.38 Million	-12.47%
2011-12-31	€23.83 Million ≈ $27.86 Million	+6.35%
2010-12-31	€22.40 Million ≈ $26.19 Million	+7.37%
2009-12-31	€20.87 Million ≈ $24.39 Million	+9.68%
2008-12-31	€19.02 Million ≈ $22.24 Million	-4.30%
2007-12-31	€19.88 Million ≈ $23.24 Million	+1.99%
2006-12-31	€19.49 Million ≈ $22.79 Million	+35.95%
2005-12-31	€14.34 Million ≈ $16.76 Million	--

Equity Component Analysis

This analysis shows how different components contribute to Clinica Baviera's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have grown by 420.5% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2024)

Component	Amount	Percentage
Retained Earnings	€40.20 Million	41.48%
Common Stock	€1.63 Million	1.68%
Other Comprehensive Income	€59.33 Million	61.21%
Total Equity	€96.92 Million	100.00%

Clinica Baviera Competitors by Market Cap

The table below lists competitors of Clinica Baviera ranked by their market capitalization.

Company	Market Cap
China Railway Signal & Communication Corporation Limited F:RS3	$842.44 Million
Hangzhou Huaguang Advanced Welding Materials Co Ltd SHG:688379	$842.62 Million
New Mountain Finance Corporation NASDAQ:NMFC	$842.78 Million
Close Brothers Group plc F:CS3	$843.01 Million
Lighthouse Capital Ltd JSE:LTE	$842.24 Million
Dividend 15 Split Corp TO:DFN	$842.11 Million
SDIC Zhonglu Fruit Juice Co Ltd SHG:600962	$841.83 Million
Radius Recycling, Inc. NASDAQ:RDUS	$841.73 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Clinica Baviera's equity between the two most recent reporting periods.

Equity Growth Insights

From 2023 to 2024, total equity changed from 90,996,308 to 96,920,000, a change of 5,923,692 (6.5%).
Net income of 40,205,000 contributed positively to equity growth.
Dividend payments of 25,890,000 reduced retained earnings.
Share repurchases of 10,240,000 reduced equity.
New share issuances of 1,431,000 increased equity.
Other comprehensive income increased equity by 11,042,431.
Other factors decreased equity by 10,624,739.

Equity Change Factors (2023 to 2024)

Factor	Impact	Contribution
Net Income	€40.20 Million	+41.48%
Dividends Paid	€25.89 Million	-26.71%
Share Repurchases	€10.24 Million	-10.57%
Share Issuances	€1.43 Million	+1.48%
Other Comprehensive Income	€11.04 Million	+11.39%
Other Changes	€-10.62 Million	-10.96%
Total Change	€-	6.51%

Book Value vs Market Value Analysis

This analysis compares Clinica Baviera's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 9.44x
The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
The price-to-book ratio has decreased from 122.95x to 9.44x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2005-12-31	€0.46	€56.20	x
2006-12-31	€1.19	€56.20	x
2007-12-31	€1.21	€56.20	x
2008-12-31	€1.17	€56.20	x
2009-12-31	€1.28	€56.20	x
2010-12-31	€1.38	€56.20	x
2011-12-31	€1.46	€56.20	x
2012-12-31	€1.31	€56.20	x
2013-12-31	€1.53	€56.20	x
2014-12-31	€1.22	€56.20	x
2015-12-31	€1.29	€56.20	x
2016-12-31	€1.13	€56.20	x
2017-12-31	€1.51	€56.20	x
2018-12-31	€1.75	€56.20	x
2019-12-31	€1.88	€56.20	x
2020-12-31	€2.73	€56.20	x
2021-12-31	€3.35	€56.20	x
2022-12-31	€4.13	€56.20	x
2023-12-31	€5.58	€56.20	x
2024-12-31	€5.95	€56.20	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Clinica Baviera utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): 41.48%
The company demonstrates strong efficiency in generating profits from shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: 15.31%
• Asset Turnover: 1.24x
• Equity Multiplier: 2.19x
Recent ROE (41.48%) is above the historical average (0.41%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2005	-261.38%	-44.66%	1.44x	4.06x	€-20.12 Million
2006	-136.01%	-41.40%	1.46x	2.24x	€-28.23 Million
2007	-120.54%	-30.31%	1.73x	2.30x	€-25.73 Million
2008	35.44%	7.69%	1.37x	3.36x	€4.86 Million
2009	8.92%	2.24%	1.42x	2.82x	€-225.74K
2010	23.38%	5.84%	1.58x	2.54x	€3.00 Million
2011	22.78%	5.77%	1.62x	2.44x	€3.03 Million
2012	-3.00%	-0.71%	1.74x	2.42x	€-2.78 Million
2013	18.85%	5.88%	1.66x	1.94x	€2.21 Million
2014	20.07%	4.83%	1.68x	2.46x	€2.00 Million
2015	22.97%	5.66%	1.84x	2.20x	€2.73 Million
2016	42.94%	8.68%	1.96x	2.53x	€6.09 Million
2017	40.17%	9.89%	1.85x	2.20x	€7.42 Million
2018	41.80%	10.90%	1.96x	1.96x	€9.06 Million
2019	42.17%	10.38%	1.22x	3.32x	€9.84 Million
2020	31.76%	11.53%	1.01x	2.72x	€9.68 Million
2021	51.15%	16.17%	1.29x	2.45x	€22.47 Million
2022	44.77%	15.19%	1.32x	2.23x	€23.41 Million
2023	40.39%	16.34%	1.26x	1.96x	€27.65 Million
2024	41.48%	15.31%	1.24x	2.19x	€30.51 Million

Industry Comparison

This section compares Clinica Baviera's net assets metrics with peer companies in the Diagnostics & Research industry.

Industry Context

Industry: Diagnostics & Research
Average net assets among peers: $5,529,918
Average return on equity (ROE) among peers: -25.85%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Clinica Baviera (CBAV)	€97.36 Million	-261.38%	1.34x	$842.36 Million
Euroespes S.A. (EEP)	$2.75 Million	6.52%	1.31x	$3.95 Million
Pangaea Oncology S.A. (PANG)	$8.31 Million	-58.22%	1.03x	$56.33 Million

About Clinica Baviera

MC:CBAV Spain Diagnostics & Research

Market Cap

$1.05 Billion

€900.01 Million EUR

Market Cap Rank

#9968 Global

#69 in Spain

Share Price

€56.20

Change (1 day)

+0.00%

52-Week Range

€37.30 - €56.20

All Time High

€56.20